Faculty in our discipline possess a broad range of expertise in cancer research including genomics/proteomics, cell signaling and receptor biology, tumor immunology, DNA repair, RNA biology, metastasis and tumor microenvironment, radiology and radiation therapy, structural biology, drug discovery, chemoprevention, experimental therapeutics, and clinical trials.
Our faculty bring in nearly $50M in funding per year, from NIH institutes including NCI, NLM, NIA, NEI, NIGMS, NIEHS, NIDDK, NIAID, NIAMS, NICHD, NIDCR, NCCIH, from foundations including Avon Foundation, St. Baldrick’s Foundation, Barker Foundation, Edward P. Evans Foundation, Hyundai Hope on Wheels, Susan G. Komen Foundation, Albert & Bessie Mae Kronkosky Charitable Foundation, Morris Lichtenstein Foundation, Morrison Trust, Ovarian Cancer Research Fund, Wiliam and Ella Owens Medical Research Foundation, San Antonio Medical Foundation, Thrivewell Cancer Foundation, Max and Minnie Tomerlin Voelker Fund, Robert A. Welch Foundation, and from AMRAA, Department of the Army, American Heart Association, American Diabetes Association, American Cancer Research Center and Foundation, Cancer Prevention and Research Institute of Texas, NASA, and the National Space Biomedical Research Institute.
Our faculty have funded collaborations with investigators at Albert Einstein College of Medicine, Baylor College of Medicine, Children’s Hospital of Philadelphia, Centre Leon Bedard, Duquesne University, Emory University, Fred Hutchinson Cancer Research Center, Georgia Regents University, Medical University of South Carolina, Midwestern University, Northwestern University, Oklahoma Medical Research Foundation, Oregon Health Science University, Stanford University, Texas Biomedical Research Institute, Texas Tech University Health Science Center, The Ohio State University, University of Alabama at Birmingham, University of Michigan, University of Oklahoma, University of Southern California, UT Austin, UT Dallas, UT MD Anderson, UT San Antonio, UT Southwestern, University of Utah and Washington University in St. Louis, and partnerships with companies, including Compugen, Eisai, miRNA Therapeutics, NanoTX Therapeutics, Santalis Pharmaceuticals, and Zealand Pharma.
These experienced mentors guide the trainees to develop and execute a research project and aid them in the development of independent and productive careers in cancer research.